Related references
Note: Only part of the references are listed.The importance of indole and azaindole scaffold in the development of antitumor agents
Yu Han et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Azaindole therapeutic agents
Damoder Reddy Motati et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
7-Azaindole Analogues as Bioactive Agents and Recent Results
Neha Sharma et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)
Peficitinib: First Global Approval
Anthony Markham et al.
DRUGS (2019)
7-Azaindole: A Versatile Scaffold for Developing Kinase Inhibitors
Takayuki Irie et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2018)
2-Hydroxyindoline-3-triethylammonium Bromide: A Reagent for Formal C3-Electrophilic Reactions of Indoles
Takumi Abe et al.
ORGANIC LETTERS (2017)
Sodium Hypochlorite Pentahydrate Crystals (NaOCl•5H2O): A Convenient and Environmentally Benign Oxidant for Organic Synthesis
Masayuki Kirihara et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2017)
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma
David A. Sandham et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
The Azaindole Framework in the Design of Kinase Inhibitors
Jean-Yves Merour et al.
MOLECULES (2014)
Identification and optimisation of 7-azaindole PAK1 inhibitors with improved potency and kinase selectivity
William McCoull et al.
MEDCHEMCOMM (2014)
PAK signalling during the development and progression of cancer
Maria Radu et al.
NATURE REVIEWS CANCER (2014)
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases
David A. Sandham et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Vemurafenib: the first drug approved for BRAF-mutant cancer
Gideon Bollag et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
7-Azaindole-3-acetic acid derivatives: Potent and selective CRTh2 receptor antagonists
David A. Sandham et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Share Paper
